Application of recombinant human bone morphogenetic protein-2 for the surgical management of Medication-Related Osteonecrosis of the Jaw in patients with osteoporosis
Application of recombinant human bone morphogenetic protein-2 for the surgical management of Medication-Related Osteonecrosis of the Jaw in patients with osteoporosis. // Journal of Cranio-Maxillofacial Surgery. – URL: https://www.sciencedirect.com/science/article/pii/S1010518226054727?dgcid=rss_sd_all
Application of recombinant human bone morphogenetic protein-2 for the surgical management of Medication-Related Osteonecrosis of the Jaw in patients with osteoporosis. Journal of Cranio-Maxillofacial Surgery. https://www.sciencedirect.com/science/article/pii/S1010518226054727?dgcid=rss_sd_all
“Application of recombinant human bone morphogenetic protein-2 for the surgical management of Medication-Related Osteonecrosis of the Jaw in patients with osteoporosis.” Journal of Cranio-Maxillofacial Surgery.
@article{article52855,
title = {Application of recombinant human bone morphogenetic protein-2 for the surgical management of Medication-Related Osteonecrosis of the Jaw in patients with osteoporosis},
journal = {Journal of Cranio-Maxillofacial Surgery},
url = {https://www.sciencedirect.com/science/article/pii/S1010518226054727?dgcid=rss_sd_all}
}